Stay updated on BIO89-100 Multiple Dose in NASH Clinical Trial
Sign up to get notified when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.

Latest updates to the BIO89-100 Multiple Dose in NASH Clinical Trial page
- Check7 days agoChange DetectedThe screenshots show only layout and styling adjustments; core study information such as eligibility criteria, enrollment numbers, and location lists appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

 - Check14 days agoNo Change Detected
 - Check21 days agoNo Change Detected
 - Check29 days agoChange DetectedSignificant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.SummaryDifference3%

 - Check36 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

 - Check50 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 and removed the 'Back to Top' link; no core content changes are evident.SummaryDifference0.2%

 - Check57 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

 - Check64 days agoChange DetectedThe web page has been updated to include new facility information, publications related to clinical trials, and additional topics on drug safety and metabolic diseases, while removing outdated location details and certain related topics.SummaryDifference9%

 
Stay in the know with updates to BIO89-100 Multiple Dose in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BIO89-100 Multiple Dose in NASH Clinical Trial page.